Class II · Moderate risk
QUAD-MIX 30MG/3MG/60MCG/0.2 Injectable
Lack of Assurance of Sterility
FDA Drug Recalls
437 recalls, newest first
Class II · Moderate risk
QUAD-MIX 30/2/60/0.15 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 50/2.5/25 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/2/40 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/2/20 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/1/60 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/1/40 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/1/20 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
TRI-MIX 30/1/10 Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Test Cyp/Prop
Lack of Assurance of Sterility
Class II · Moderate risk
Test Cyp/Dhea
Lack of Assurance of Sterility
Class II · Moderate risk
Test Cyp/Dhea
Lack of Assurance of Sterility
Class II · Moderate risk
TEST CYP (Grapeseed)
Lack of Assurance of Sterility
Class II · Moderate risk
Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin Acetate 1 MG/ML Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
MIC/B12/L-Carn
Lack of Assurance of Sterility
Class II · Moderate risk
MIC/B12 25/50/50/1 MG/ML Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
L-Carnitine 500 mg/mL Injectable
Lack of Assurance of Sterility
Class III · Low risk
Crest 3D White Fluoride Anticavity Toothpaste
Labeling: Missing label: the product tube was missing a label and contained a different formulation.
Class II · Moderate risk
Artri King Reforzado con Ortiga Omega 3 Tablets
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Class II · Moderate risk
Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Class I · High risk
Artri King Reforzado con Ortiga Omega 3 Tablets
Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation.
Class II · Moderate risk
Amino Blend Glutamine 30 mg/mL Ornithine HCL 50 mg/mL Arginine…
Lack of assurance of sterility.